Serum markers predicting clinical response to anti-TNFalpha antibodies in patients with psoriatic arthritis

Details for Australian Patent Application No. 2010276665 (hide)

Owner Janssen Biotech, Inc.

Inventors Wagner, Carrie; Visvanathan, Sudha

Agent Shelston IP

Pub. Number AU-A-2010276665

PCT Pub. Number WO2011/014349

Priority 61/228,994 28.07.09 US

Filing date 12 July 2010

Wipo publication date 3 February 2011

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

23 February 2012 PCT application entered the National Phase

  PCT publication WO2011/014349 Priority application(s): WO2011/014349

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010276674-Methods and systems for associating and providing media content of different types which share attributes

2010276661-Systems and methods for removing heavy hydrocarbons and acid gases from a hydrocarbon gas stream